BM
Brandywine Managers Portfolio holdings
AUM
$101M
1-Year Return
24.43%
This Quarter Return
-3.74%
1 Year Return
+24.43%
3 Year Return
+74.73%
5 Year Return
+125.12%
10 Year Return
+356.43%
AUM
$83.4M
AUM Growth
-$11.5M
(-12%)
Cap. Flow
-$6.97M
Cap. Flow
% of AUM
-8.36%
Top 10 Holdings %
Top 10 Hldgs %
83.19%
Holding
37
New
–
Increased
2
Reduced
6
Closed
2
Top Buys
| 1 |
MongoDB
MDB
|
$113K |
| 2 |
10x Genomics
TXG
|
$77.4K |
Top Sells
| 1 |
iShares MSCI ACWI ETF
ACWI
|
$6.05M |
| 2 |
Viking Therapeutics
VKTX
|
$325K |
| 3 |
Mobileye
MBLY
|
$260K |
| 4 |
Okta
OKTA
|
$166K |
| 5 |
Veeva Systems
VEEV
|
$153K |
Sector Composition
| 1 | Technology | 46.26% |
| 2 | Healthcare | 11.56% |
| 3 | Financials | 1.17% |
| 4 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
SentinelOne
S
$6.03B
| $345K | 0.41% |
19,001
| – | – |
|
27
Novo Nordisk
NVO
$250B
| $293K | 0.35% |
4,222
| – | – |
|
28
Moderna
MRNA
$9.44B
| $270K | 0.32% |
9,510
| – | – |
|
29
Klaviyo
KVYO
$9.3B
| $263K | 0.32% |
8,692
| – | – |
|
30
Twilio
TWLO
$16.3B
| $231K | 0.28% |
2,357
| – | – |
|
31
Beam Therapeutics
BEAM
$1.87B
| $221K | 0.26% |
11,306
| – | – |
|
32
Structure Therapeutics
GPCR
$1.12B
| $191K | 0.23% |
11,057
| – | – |
|
|
33
10x Genomics
TXG
$1.67B
| $165K | 0.2% |
18,938
+8,865
| +88% | +$77.4K |
|
34
Relay Therapeutics
RLAY
$695M
| $101K | 0.12% |
38,429
| – | – |
|
35
AbCellera Biologics
ABCL
$1.22B
| $63.5K | 0.08% |
28,488
| – | – |
|
|
36
Mobileye
MBLY
$11.9B
| – | – |
-13,067
| Closed | -$260K |
|
|
37
Viking Therapeutics
VKTX
$2.96B
| – | – |
-8,082
| Closed | -$325K |
|